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To evaluate acute and follow-up changes in left ventricular
diastolic performance, simultaneous digital left ventriculog-
raphy and micromanometry were performed in 49 patients
undergoing aortic balloon valvuloplasty. All patients im-
proved symptomatically after valvuloplasty, and 26 re-
turned 6.3 ± 1.5 months later for follow-up catheterization.
Immediately after valvuloplasty, aortic valve area in-
creased (before 0.5 ± 0.2 versus after 0.8 ± 0.2 cm2, p <
0.01), cardiac output (before 4.3 ± 1.2 versus after 4.4 ±
1.3 liters/min) and ejection fraction (before 51 ± 18%
versus after 52 ± 17%)did not change and diastolic indexes
worsened, signified by a decrease in peak filling rate (before
247 ± 80 versus after 226 ± 78 mils, p < 0.01) and increase
in the time constant of isovolumetric relaxation (T) (before
78 ± 29 versus after 96 ± 40 ms, p < 0.01) and the modulus
of chamber stiffness (before 0.107 ± 0.071 versus after
0.141 ± 0.083, p < 0.01).
At follow-up catheterization, 16 patients continued to
have symptomatic improvement (group 1) and 10 had
Percutaneous aortic balloon valvuloplasty is an alternative
treatment for patients with valvular aortic stenosis who
either refuse or present an unacceptable risk for surgical
valve replacement. Symptomatic improvement occurs in
most patients immediately after valvuloplasty (1-10) and is
maintained in 30% to 50% of patients followed up for 6
months (2-10), Although data exist regarding acute and late
changes in aortic valve area and left ventricular systolic
performance after valvuloplasty (1-10), few data are avail-
able regarding acute and late changes in diastolic perfor-
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recurrence of symptoms (group 2). Aortic valve area,
cardiac output and ejection fraction at follow-up catheter-
ization in both groups were similar and unchanged from
values before valvuloplasty. However, diastolic indexes and
left ventricular mass were improved compared with values
before valvuloplasty in group 1 and worse in group 2 as
follows: peak filling rate: group 1 +8% versus group 2
-20%, P = 0.001; time constant of isovolumetric relax-
ation: group 1 -11 % versus group 2 +35%, P =0.008;
chamber stiffness: group 1 -27% versus group 2 +26%,
P =0.001; mass: group 1 -9% versus group 2 +6%, P =
0.004.
These data indicate that 1) diastolic performance wors-
ens immediately after valvuloplasty, consistent with the
development of ischemia during balloon inflation; and 2)
changes in left ventricular diastolic indexes and mass,
rather than aortic valve area or systolic indexes, correlate
best with symptomatic status 6 months after valvuloplasty.
(J Am Coil CardioI1990;16:795-803)
mance (II). Given that diastolic performance indexes are
sensitive to the development of myocardial ischemia (12-15),
acute changes in these indexes after valvuloplasty may
provide important insights into the development of the global
ischemia that is postulated to occur during valvuloplasty.
Furthermore, given that abnormalities of diastolic perfor-
mance may be a primary cause of symptoms in patients with
aortic stenosis (16-21), improved diastolic performance may
account for improved symptoms late after valvuloplasty. To
examine these issues, invasively measured hemodynamic
indexes of diastolic performance were examined in a con-
secutive series of patients before. immediately after and 6
months after successful aortic valvuloplasty.
Methods
Study patients. Between April 1987 and October 1988, 69
patients underwent successful and uncomplicated aortic
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valvuloplasty. From this group. 20 patients were excluded
because of either hemodynamic instability prompting urgent
valvuloplasty (n = 3) or technically inadequate hemody-
namic (n = 5) or echocardiographic data. or both (n = 12).
The remaining 49 subjects had compensated New York
Heart Association functional class III or IV congestive heart
failure or angina at the time of valvuloplasty. By clinical
necessity, all medications were continued. Patients gave
informed consent to a protocol approved by the institutional
review board for all phases of this study.
Echocardiography. Two-dimensional. M-mode and Dop-
pler echocardiograms were obtained immediately before and
after valvuloplasty with use of a Hewlett-Packard 77020A or
77020CF imaging system fitted with either a 2.5 or 3.5 MHz
transducer. Echocardiograms were analyzed off-line with
use of a commercially available computer and software
(Nova Microsonics). Chamber size and wall thickness were
measured from the parasternal M-mode tracing at the mitral
chordal level. with values averaged for three consecutive
beats (22). Left ventricular mass was measured by an
automated biplane Simpson's rule method, using the average
value of manually traced end-diastolic epicardial and en-
docardial outlines from three consecutive cardiac cycles in
apical two and four chamber views (23.24). The mean values
for inter- and intraobserver variability for mass measure-
ments, each performed at least 30 days apart. were 4.2% and
3.59(. respectively. Wall stress was determined by the
method of Grossman et al. (25), using chamber size and wall
thickness echocardiographic measurements and microman-
ometer left ventricular pressures obtained within 5 to 10 min
of each other (26.27).
Hemodynamics. Right and left heart catheterization was
performed from the femoral approach. Baseline hemody-
namic measurements were obtained at least 15 min after the
patient had undergone coronary arteriography and aortogra-
phy using a low osmolarity. nonionic contrast agent. Coro-
nary artery disease was defined as ::::.75% luminal diameter
narrowing. Expired gas analysis was performed with a
Sensormedics MMC Horizon system. Right heart and pul-
monary artery pressures were obtained with a 7F Critikon
catheter. Blood oxygen content and saturation were mea-
sured on a calibrated Instruments Laboratories 282 CO-
oximeter. Cardiac output was by the direct Fick method.
Simultaneous left l'entriClllar and aortic pressures were
measured with an 8F dual sensor, high fidelity. Millar
micromanometer catheter. Micromanometer pressure cath-
eters were balanced externally and then to a fluid-filled
lumen pressure once inserted into the ventricle. Data were
transferred to a Hewlett-Packard 8086A computerized pres-
sure recorder and displayed on a Gould 1000-C electronic
strip chart. All pressure data. the maximal rate of rise of left
ventricular pressure (dP/dt) and the electrocardiogram were
recorded at 5 ms intervals. The analog data were digitally
converted and simultaneously stored with 30 frames/sdigital
ventriculography data using an ADAC 4IOO-C system.
A diRitall'entriculoRram was performed at held inspira-
tion. utilizing a 256 x 256 x 8 bit deep matrix in the 30° right
anterior oblique projection. Thirty-five to 40 ml of nonionic
contrast medium was power injected at 12 to 15 mils directly
into the ventricle. Ventricular ectopic and immediate pre-
and postectopic beats were excluded. The first five to six
beats after contrast injection were used for analysis. Digital
data were mask-mode subtracted using R wave-gated
subtraction methods during postprocessing analysis. Ven-
tricular volumes were derived using semiautomated com-
mercially available software. Calibration factors were deter-
mined by an imaging grid. Volumetric data obtained in this
manner had previously been validated in this laboratory
using 20 human heart casts of known volumes (unpublished
observations). from which a regression equation relating the
true volume to the volume obtained by digital subtraction
ventriculography had been derived (28). The resulting vol-
ume curve and time-matched pressure data were used to
construct a pressure-volume loop for each study.
Aortic m/l'e area was calculated by the Gorlin equation
(29). Aortic and mitral insufficiency were graded at catheter-
ization using previously established criteria (0). Left ven-
tricular end-diastolic pressure was obtained at the peak of
the R wave on the ECG. The time constant of isovolumetric
relaxation (7) was determined by the method of Weiss et al.
ot) from the linear relation of left ventricular pressure and
dP/dt in early diastole. determined between peak -dP/dt to
5 mm Hg above the end-diastolic pressure. The mean
correlation coefficient. using 7 to 20 data points per study.
was -0.959 (range -0.912 to -0.997).
Instantaneous diastolicjillinR rates were calculated every
5 ms after mitral valve opening. based on volumes derived
from digital ventriculography. The raw volume-time data
were smoothed by digital filtering using a fifth-grade moving
average (32). The instantaneous slope (dV/dt) of the
smoothed volume-time curve was computed and plotted,
with peak filling rate defined as the maximal increase in
volume over a 5 ms interval during the first half of diastole.
Chamber stiffness was determined over the range of
lowest diastolic pressure to end-diastolic pressure by the
method of Gaasch et al. (33) according to the equation: P =
be Kpv. When differentiated. this equation transforms to
dP/dV = Kp + b. where P = pressure. V '" volume, Kp = the
modulus of chamber stiffness and b is a constant.
Valvuloplasty technique. Valvuloplasty was performed
by a retrograde arterial technique as previously described
(1). All patients had at least two 10 to 40 s dilations using
either single 20 or 23 mm or double 10 and 20 mm aortic
valvuloplasty balloons. After valvuloplasty, digital left ven·
triculography. micromanometry and echocardiography were
repeated within 10 min of the last dilation.
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Figure 2, Symptomatic grouping of 49 patients before aortic balloon
valvuloplasty (PBAV) and 26 patients at follow-up catheterization.
Functional class = highest New York Heart Association class for
angina or heart failure. Numbers in boxes = numbers of patients.
Figure 1. Patient selection and outcome. Numbers in parentheses =
numbers of patients. AVR = aortic valve replacement; Cath =
catheterization; PBAV = percutaneous aortic balloon valvulo-
plasty.
Follow-up data. All 49 patients undergoing aortic balloon
valvuloplasty were discharged from the hospital with symp-
tomatic improvement. Follow-up symptomatic status was
assessed by periodic outpatient clinic visits and telephone
interviews. The clinical course of all initially eligible patients
is displayed in Figure I. Patients who were alive and had not
had aortic valve surgery were eligible for follow-up cathe-
terization. Of 36 eligible candidates, 26 consented to repeat
catheterization, which was performed between 5 and 7
months after valvuloplasty in 23 patients and between 4 and
II months in all 26 patients. No patient had a cardiac event
during the time from valvuloplasty to follow-up catheteriza-
tion. All patients were clinically stable at the time of repeat
catheterization.
Patients were divided into two R'oups at the time of
follow-up catheterization according to symptom status (Fig.
2). Group I consisted of 16 patients who were symptomati-
cally improved at follow-up catheterization, as defined by
New York Heart Association functional class I or II for both
congestive heart failure and angina. Group 2 consisted of 10
patients who had recurrent symptoms, with class III or IV
congestive heart failure or angina. Medications in use at the
time of repeat catheterization were continued. At follow-up
catheterization, all subjects underwent echocardiography.
immediately followed by simultaneous digital left ventricu-
lography and micromanometry. Repeat valvuloplasty was
performed in seven patients at this time. All data were
analyzed without knowledge of symptom status.
Statistical analysis. Baseline clinical characteristics be-
tween groups were compared by unpaired Student's t tests
for continuous variables and chi-square analysis for dichot-
omous variables. Intra- and intergroup comparisons of all
echocardiographic and hemodynamic variables were by
Wilcoxon two-sample tests. Comparisons of differences be-
tween groups for interval changes in variables were per-
formed using the Wilcoxon signed-rank test. A p value
<0.05 was considered statistically significant.
Results
Baseline characteristics. Baseline characteristics of the 49
patients undergoing valvuloplasty as well as of the two
patient groups at follow-up catheterization are shown in
Table I. There were no differences among the 49 patients at
baseline evaluation and between either group at follow-up
catheterization in terms of age, gender. incidence of previ-
ous myocardial infarction noted by either electrocardio-
graphic mCG) criteria or history, or prevalence or severity
of coronary artery disease. By virtue of fewer symptoms,
patients in group I were taking fewer medications and at
lower dosages than were those in group 2. Valvuloplasty in
both groups was accomplished with similar balloon sizes and
number and duration of balloon inflations. Both groups
underwent follow-up catheterization at similar intervals after
valvuloplasty.
Acute hemodynamic changes. Hemodynamic variables
before and after valvuloplasty for all 49 patients are shown in
Table 2. Heart rate, cardiac output and ejection fraction
were unchanged, but mean aortic gradient decreased and
mean aortic valve area increased. Left ventricular end-
diastolic pressure was unchanged, whereas end-diastolic
volume decreased, probably as a result of procedure-related
blood loss. All diastolic indexes worsened, with an increase
in peak -dP/dt. T and chamber stiffness and a decrease in
peak filling rate. Both peak and end-systolic wall stress were
reduced as a result of a decrease in left ventricular systolic
pressure.
ChanRes in both aortic and mitral valve regurgitation
were minimal after valvuloplasty. Mitral insufficiency was
noted in 20 patients before valvuloplasty (3+ in 3 patients,
2+ in 4 and I+ in 13); it was unchanged in 18 patients and
decreased by one grade in 2 after valvuloplasty. New mild
(I +) mitral insufficiency was detected in two patients. Aortic
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Follow-Up Catheterization
Age (yr)
Men/women
Symptoms
CHF class III or IV
CHF class I or II
Angina class III or IV
Angina class I or II
Previous MI
Coronary artery disease
I vessel
2 vessel
3 vessel
Medications
Diuretic drugs
Calcium channel antagonists
Nitrates
Valvuloplasty procedure
Balloon size (mm)
20
23
10 + 20
No. of inflations
Max duration (s)
Follow-up
Time (mo.)
Range (mo.)
Initial
Valvuloplasty
All Subjects
(n = 49)
74 ± 8
22/27
45 (92%)
316%)
21 (43%)
7 (14%1
II (22%)
26 (53'7r.l
]()
9
7
41 (84%)
26153%)
22 (45%)
40182%1
5 (10%)
4 (8%)
3.9 ± 2.2
25 ± 10
Improved Symptoms
(group I. n = 16)
73 ± 6
8/8
14188\7,)
8 (50\7,)
4
6 (38\7,)
3
II (70\7,1
6 138\7, 1
7144%1
14 (88%)
I 16\7,)
116%)
3.7 ± 2.4
31 ± 14
6.4 ± 1.0
(5.1-9.2)
Recurrent Symptoms
(group 2. n = 10)
75 ± 7
4/6
6160%)
4140%)
8 (80%)
o
2 (20%)
5150%1
I
3
I
101100\7,)
6160%)
8 180\7,)
8 (80%)
2120\7,)
o
3.2 ± 2.5
26 ± II
6.5±2.1
(4.0-11.4)
Values for age. number and duration of inflations and follow-up time are mean values ± I SO. All other values
represent number of patients. Balloon size = largest balloon used: CHF = congestive heart failure: class = New
York Heart Association functional class: Max duration = duration of longest balloon inflation for the largest balloon
used; MI = myocardial infarction.
insufficiency was noted in 42 patients before valvuloplasty
(3+ in 2 patients, 2+ in 12 and I+ in 28); it increased by one
grade in 2 patients, decreased by one grade in 4 and was
unchanged in 36. New mild (1 +) aortic insufficiency was
noted in two patients.
Hemodynamics at follow-up. Follow-up echocardio-
graphic and hemodynamic assessment was performed in 26
patients (16 in group 1and 10 in group 2). Of the 10 patients
who refused repeat catheterization, symptom status was
similarly distributed as in the group consenting to catheter-
ization, with 6 patients having symptomatic improvement
and 4 having recurrent symptoms. Hemodynamic and echo-
cardiographic findings immediately before or after valvulo-
plasty were not different between those patients returning
for follow-up catheterization and those who did not. Thir-
teen patients were not eligible for follow-up catheterization
because of either aortic valve replacement (n = 3) or death
(n = 10). All 10 patients who died had a cardiac death, with
8 dying because of progressive heart failure and 2 dying
suddenly. Clinical and hemodynamic characteristics before
and after valvuloplasty were similar in all respects between
the group of patients who died and those who did not, except
for a lower baseline ejection fraction in the former (37 ± 13%
versus 54 ± 17%. p < 0.05).
Tahle 3 ShOll'S hemodynamic and echocardiographic var-
iahles hefore and after valvuloplasty and at follow-up cath-
eterization in groups I and 2. Both groups were comparable
in all respects before and after valvuloplasty and at follow-up
catheterization. except for lower T and chamber stiffness
values and higher peak filling rates in group I than in group
2. The median percent changes from before valvuloplasty to
follow-up catheterization for aortic valve area and indexes of
left ventricular mass and systolic and diastolic performance
are shown in Figure 3. No difference between the groups was
detected in terms of the change in aortic valve area, cardiac
output or ejection fraction. However, all diastolic indexes
had worsened in group 2, in contrast to the improvement
noted in group 1. This was also accompanied by a reduction
in the left ventricular mass index in group I compared with
group 2, without an accompanying change in wall thickness
lACC Vol. 16. No.4
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Table 2. Immediate Hemodynamic Changes After Valvuloplasty
'p < 0.05 compared with before valvuloplasty. -dP/dt = maximal rate of
decrease of left ventricular pressure: EDWS = end-diastolic wall stress:
ESWS = end-systolic wall stress: LV = left ventricular: LVlDd = left
ventricular end-diastolic internal dimension: Kr = modulus of chamber
stiffness: PSWS = peak systolic wall stress: 1 = time constant of isovolumet-
ric relaxation.
in either group. Although not indicated in Figure 3, heart
rate. mean aortic gradient. left ventricular systolic pressure.
frequency or severity of valvular regurgitation. wall stress
and chamber dimensions were equal to prevalvuloplasty
values and were not different between the two groups.
Discussion
ACllte Hemodynamic Cha/1/{es
Relation to previous studies. Changes in left ventricular
diastolic performance occurring during and after aortic val-
vuloplasty have received little attention. Stoddard et al. (II)
noted prolongation in 7' and a reduction in peak -dP/dt
immediately after valvuloplasty. Nishimura et al. (34) ob-
served alterations in the Doppler diastolic flow pattern.
suggesting restriction of mitral flow during balloon occlusion
that persisted after balloon deflation. The findings of our
study extend these observations by demonstrating worsen-
ing of indexes reflecting all aspects of diastolic performance.
including isovolumetric relaxation. rapid passive filling and
chamber compliance shortly after valvuloplasty.
Potential mechanisms. Worsening of diastolic perfor-
mance is likely a result of transient myocardial ischemia that
occurs during balloon occlusion of the aortic outflow tract.
This may occur by I) a decrease in aortic systolic and
diastolic pressures. resulting in a lowered coronary perfu-
sion pressure and hence diminished myocardial oxygen
delivery; and 2) an acute elevation in afterload that results in
increased myocardial oxygen demand (35-37). Decreases in
coronary blood flow and an increase in myocardial oxygen
uptake and lactate production have been reported to accom-
pany valvuloplasty (36). The resultant myocardial "stun-
ning" may take several minutes to days to resolve (38).
Although in most cases transient balloon occlusion is clini-
cally well tolerated. hypotension. ventricular arrhythmias.
angina and myocardial infarction may all occur during and
immediately after valvuloplasty (1.6).
No significant change in ejection fraction was noted in
this study. Previous reports have noted both improvement
(1-5) and worsening 05.36) of systolic indexes after valvu-
loplasty. Because diastolic indexes may be more sensitive to
the effects of myocardial ischemia than systolic indexes
(12-15), it is not surprising that diastolic indexes may
worsen. without a change in systolic indexes.
Potential limitations. Confounding factors to consider in
evaluating changes in diastolic indexes include the effects of
contrast injections. changes in heart rate. valvular insuffi-
ciency. loading conditions and baseline left ventricular filling
pattern. Small volumes of low osmolarity contrast agents
have only minimal effects on both systolic arid diastolic
hemodynamics. particularly when assessed within six beats
of contrast injection (39-41). Heart rate al1d the frequency
and severity of valvular regurgitation were similar both
before and after valvuloplasty.
Loadil/R cOl/ditiol/s \\'ere, 110\\'el'er, altered by I'all'u/o-
p/astv. Preload. as assessed by end-diastolic volume. and
afterload. as assessed by end-systolic wall stress. were both
reduced after valvuloplasty. Although peak -dP/dt. peak
filling rate and chamber stiffness may be affected by changes
in load. 7' appears to be less affected (42-45). Furthermore.
Diver et al. (46) recently demonstrated that an isolated
reduction in preload and afterload. resulting from nitroprus-
side infusion in patients with aortic stenosis. results in no
change in T or peak filling rate. despite lowering of both
end-diastolic pressure and volume.
A limitation of peak fillil/R rate as an index of diastolic
pe,:!iml/al/ce in aortic stenosis is that although mild diastolic
dysfunction may cause a decrease in early diastolic filling.
early diastolic filling may be the greatest contributor to left
ventricular filling when the most profound diastolic perfor-
mance abnormalities exist (19,47,481. It is noteworthy that
although most patients exhibited a decline in peak filling rate
after valvuloplasty. all six patients who had an increase in
peak filling rate had elevated (>20 mm Hg) baseline left
ventricular end-diastolic pressure (mean ± SD 30 ± 8 mm
Hg). Thus. an increase in peak filling rate in these patients
may also signify worsening diastolic performance.
With respect to chamber stiffness. it is possible that the
increase in the modulus of chamber stiffness after valvulo-
77 :!: 14
0.8 :!: n.2*
35 :!: 12*
180:!: 32*
4.4 :!: 1.3
52 :!: 17
24 :!: 10
After
Valvuloplasty
(n = 49)
20 :!: 9
123 :!: 43*
1.473 :!: 421 *
96 :!: 40*
226 :!: 78*
0.141 :!: n.08)·
142 :!: 58*
84 :!: 46*
19:!: 14
1.4 :!: OJ
4.4 :!: 0.8
76:!: 14
0.5 :!: 0.2
59:!: 17
209 :!: 38
4J :!: 1.2
51 :!: 18
26:!: 10
Before
Valvuloplasty
(n = 49)
22 :!: 9
130 :!: 42
1.602 :!: 420
78 :!: 29
247 :!: gO
n.107 :!: 0.071
171 :!: 71
98:!: 52
22:!: 16
1.4 :!: OJ
4.5 :!: 0.8
180:!: 48
Heart rate (beals/min)
Aortic valve area (em 2)
Mean aortic gmdient (mm Hg)
LV systolic pressure (mm Hg)
Cardiac output (liters/min)
LVejection fraction (91)
Mean pulmonary pressure
(mm Hg)
LV end-diastolic pressure (mm Hg)
LVend-diastolic volume Imil
Peak -dP/dt Imm Hg/s)
rims)
Peak filling rate (ml/s)
Kp
PSWS (X 103 dynes/cm 2)
ESWS (X 103 dynes/cm~)
EDWS (X 103 dynes/cm~)
LV posterior wall thickness (em)
LVlDd (em)
LV mass index (g/m2)
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Table 3. Immediate and Follow-Up Hemodynamic Changes in Patient Groups After Valvuloplasty
Group Pre Post Follow-Up
Heart rate (beats/min) 78 ± 14 79 ± 16 74 ± 14
2 76 ± 11 80 ± 13 77 ± II
Aortic valve area (em") 0.5 ± 0,1 0.8 ± 0.2* 0.6 ± 0.2
0.5 ± 0.1 0.8 ± 0.2* 0.5 ± 0.2
Mean aortic gradient (mm Hg) 65 ± 18 38 ± 13* 58 ± 17
2 61 ± 23 33 ± 11* 55 ± 18
LV systolic pressure (mm Hg) I 221 ± 40 187 ± 38* 223 ± 33
2 213 ± 30 188 ± 22* 217 ± 40
Cardiac output Oiters/min) I 4.7 ± 1.2 4.8 ± 1.5 4.8 ± 1.5
4.5 ± 0.9 4.4 ± 1.2 4.2 ± 1.2
LV ejection fraction (%) 59 ± 16 62 ± 15 59 ± 14
56 ± 18 57 ± 14 52 ± 15
Mean pulmonary pressure (mm Hg) 27 ± 12 25 ± 10 24 ± II
26 ± 10 23 ± II 25 ± 10
LV end-diastolic pressure (mm Hg) I 21 ± 7 19 ± 9 18 ± 8
2 19 ± 10 17 ± 8 21 ± 8
LVend-diastolic volume (ml) 128 ± 48 129 ± 50 124 ± 40
2 121 ± 34 107 ± 35 127 ± 33
Peak -dP/dt (mm Hg/s) 1.543 ± 461 1.377 ± 411* 1,838 ± 439
2 1.678 ± 274 1,468 ± 355* L742 ± 471
rIms) 80 ± 29 106 ± 42* 69 ± 16
68 ± 21 95 ± 47* 89 ± 34t
Peak filling rate (mI/s) 259 ± 99 232 ± 90* 290 ± 106
258 ± 60 246 ± 69* 213 ± 47*t
Kp 0.092 ± 0.057 0.137 ± 0.100* 0.061 ± 0.035*
0.084 ± 0.030 O.l30 ± 0.053* 0.127 ± 0.093*t
PSWS (X JOl dynes/em") 149 ± 51 122 ± 43* 160 ± 53
2 165 ± 55 137 ± 43* 167 ± 56
ESWS (X 10J dynes/em") 72 ± 38 60 ± 32* 76 ± 36
2 87 ± 36 76 ± 34* 94 ± 42
EDWS (X JOl dynes/em") 16 ± 10 14 ± 8 15 ± 9
2 18 ± 13 14 ± 9 19 ± 14
LV posterior wall thickness (em) 1.4±OJ 1.5 ± OJ 1.4±OJ
2 1.4±OJ 1.4 ± OJ 1.5 ± OJ
LVIDd (em) I 4.2 ± 0.6 4.1 ± 0.6 4.2 ± 0.6
2 4J ± 0.8 4.2 ± 0.8 4.5 ± 0.6
LV mass index (g/m") I 173 ± 45 159 ± 40
163 ± 45 174 ± 48
*p < 0.05 compared with before valvuloplasty in the same group: tp < 0.05 compared with group 1for specific
variable. Group 1 = improved symptoms (n = 16): Group 2 = recurrent symptoms (n = 10): Post = after
valvuloplasty: Pre = before valvuloplasty: other abbreviations as in Table 2.
plasty may have been due to a smaller end-diastolic volume.
This in itself would result in a steeper diastolic pressure-
volume curve unrelated to the development of myocardial
ischemia, causing an impairment in chamber compliance
(33,49),
Hemodynamic Changes at Follow-Up
Relation to previous studies. Consistent with previous
reports (3-10), only 22 (44%) of the 49 study patients had
continued symptomatic improvement at follow-up catheter-
ization. Symptom status at follow-up catheterization was not
related to baseline clinical characteristics, baseline indexes
of aortic stenosis severity or hemodynamics or changes in
aortic valve area and hemodynamics that resulted from
valvuloplasty, Furthermore, as also previously reported
(3-11), no differences between group I (improved symp-
toms) and 2 (recurrent symptoms) in either mean gradient or
aortic valve area at follow-up catheterization were noted,
nor were changes from the postvalvuloplasty aortic valve
area to follow-up aortic valve area (restenosis) able to
distinguish patients with alleviated symptoms from those
with recurrent symptoms.
The inability to relate symptoms at follow-up catheteriza-
tion to aortic valve area has led some (4) to attribute a
placebo effect to valvuloplasty. However, the discordance
JACC Vol. 16. No.4
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provement has been accompanied by regression of hypertro-
phy and improvement in both (ystolic and diastolic perfor-
mance despite the presence of a significant residual stenosis
across most prosthetic valves (47,52-54). Left ventricular
hypertrophy may regress as early as 3 to 5 weeks after valve
replacement (54). Not only may absolute wall thickness
decrease. but ventricular remodeling, characterized by
changes in both wall thickness and chamber dimension, may
occur (52-54). Diastolic performance, in particular, appears
to be closely related to ventricular mass and improves with
regression of hypertrophy (17-19). Of note. a recent stuc'y by
Safian et al. (8) indicated that some patients whose ejection
fraction improved 3 months after valvuloplasty also had a
decrease in the ratio of wall thickness to chamber dimension.
suggestive of early left ventricular remodeling.
Potential mechanisms. Valvuloplasty may improve dias-
tolic performance by causing a decrease in afterload. result-
ing in a decrease in wall stress. If maintained, a decrease in
wall stress should promote regression of hypertrophy (25). A
second beneficial effect that may contribute to improved
diastolic performance is a decrease in transvalvular aortic
gradient. resulting in improved coronary blood flow and
reserve as documented by Smucker et al. (35). A decrease in
wall stress and improvement in myocardial ischemia may
promote left ventricular remodeling and further improve-
ment in ventricular performance. In support of this mecha-
nism. patients with improved symptoms had a decrease i
ventricular mass and chamber size. but not an appreciahle
decrease in left ventricular wall thickness.
Precautions. Previous studies have emphasized that val-
vuloplasty should be regarded as a palliative procedure for
patients who present a high operative risk or are unwilling to
undergo aortic valve replacement. The results of this study
should not be taken as an endorsement that valvuloplasty is
curative. Instead, these results indicate that there is a
hemodynamic basis to explain why some patients mainlain
symptomatic improvement despite valve restenosis. Nota-
bly. 6 months after aortic valvuloplasty. improvement in
symptom status is only demonstrable in 44% of patients and
no baseline or postvalvuloplasty variables predict which
patients are likely to maintain symptomatic benefit. Further-
more. although group I (improved symptoms) had a small
decrease in left ventricular mass, this was largely due to a
reduction in cavity size and not a decrease in wall thickness.
Also. because group I had a slight yet insignificantly higher
baseline left ventricular mass than group 2. this may have
resulted in a greater ability to detect a decrease in mass in
group 1. Finally. at follow-up catheterization hath end-
systolic and peak systolic wall stress had returned to base-
line levels in group I. which may signify a continued
stimulus for further hypertrophy and loss of the hemody-
namic and symptomatic benefit occurring 6 months after
valvuloplasty. Further data are necessary to determine if
....
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Figure 3. Changes in hemodynamic and echocardiographic varia-
bles from before valvuloplasty to follow-up catheterization. Bars
represent median %change from before percutaneous aortic balloon
valvuloplasty (Pre-PBAV) to follow-up catheterization for groups I
and 2. Numbers shown below the variables represent p values that
compare the significance of changes in group I versus group 2.
AVA = aortic valve area; CO = cardiac output; EDP = end-
diastolic pressure; EDV = end-diastolic volume: EF = ejection
fraction; Kp = modulus of chamber stiffness: LVMl = left ventric-
ular mass index: PFR = peak filling rate: PWT = posterior wall
thickness: TAU = time constant of isovolumetric relaxation.
between aortic valve area and symptom status may be due to
several factors. One such factor may be that the Gorlin
equation, by virtue of the use of a fixed constant and
inaccuracy in the presence of low flow states and valve
insufficiency. is an imperfect measure of aortic stenosis
severity (50,51).
The relation of symptoms in aortic stenosis to left l'en-
tricular filllction independent of aortic mIre area is \I"el/
recof.:nized (/6-21). However. this study and others (3-11)
indicate that changes in left ventricular systolic performance
do not correlate with symptom status after aortic valvulo-
plasty. Although baseline clinical characteristics such as the
extent and severity of coronary disease and left ventricular
ejection fraction were similar in groups I and 2 and no
patient had clinical. angiographic, hemodynamic or echocar-
diographic evidence of a primary cardiomyopathy. left ven-
tricular dysfunction due to a nonvalvular. nonischemic cause
cannot be excluded.
The primary finding of this study is that symptom status 6
months after mlvuloplasty is closely related to c/wnRcs in
left ventricular diastolic pelfornwllce. This issue was also
addressed by Stoddard et al. (\ I). who found that diastolic
performance changes at follow-up study after aortic valvu-
loplasty did not correlate with functional status. Their study
was, however, limited by the fact that diastolic performance
at follow-up evaluation was assessed by Doppler mitral flow
indexes rather than hemodynamics. Data in our laboratory
(48) indicate that Doppler mitral flow indexes do not relate to
hemodynamic variables of left ventricular relaxation or
chamber stiffness in patients with aortic stenosis.
Pertinent to the results of this study are those in patients
after aortic valve replacement in whom symptomatic im-
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hemodynamic and symptomatic improvement is maintained
beyond this early follow-up period.
Conclusions. These results indicate that aortic valvulo-
plasty is an effective palliative treatment for selected pa-
tients with aortic stenosis. Immediately after valvuloplasty,
diastolic performance worsens, probably because of tran-
sient myocardial ischemia during balloon occlusion of the
aortic outflow tract. Maintained symptomatic improvement
6 months after valvuloplasty is closely related to improved
diastolic performance and not to systolic performance or
aortic valve area. Adecrease in wall stress and improvement
in myocardial ischemia, resulting in left ventricular remod-
eling and regression of hypertrophy, are the likely mecha-
nisms responsible for symptomatic and hemodynamic im-
provement. Why some patients maintain symptomatic
improvement and others do not and the further course of
those who are improved require further investigation.
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